Rachel O'ReillyOct 10, 20222 minAalto Bio Reagents Launches New Monkeypox Virus B21R-BSA Conjugate Peptides for Diagnostic TestingDublin, Ireland – 10th October 2022 - Aalto Bio Reagents Ltd., a leading global supplier of critical raw materials to the in-vitro...
Kellie MeadeMay 25, 20222 minAalto Bio Reagents Acquired by Biosynth Carbosynth to Strengthen its Global Life Science Enterprise Urs Spitz (left) – CEO and President, Biosynth Carbosynth and Philip Noone (right) – CEO, Aalto Bio Reagents Dublin, 25 May 2022 - Aalto...
Kellie MeadeMay 11, 20223 minAalto Bio Reagents Launches New Recombinant Mayaro Virus E2 Gylcoprotein, Domain A.Dublin, Ireland – May 11th 2022 – Aalto Bio Reagents Ltd., a leading global developer of critical raw materials for the development of...
Rachel O'ReillyApr 4, 20223 minAalto Bio Reagents Announces 15 Pathogen Development Strategy to Solve the World's Future DiseasesAalto Bio Reagents Ltd., a leading global developer of critical raw materials and reagents for the development of diagnostic tests, today...